Table 1 Baseline characteristics of participants
From: Utility of urinary presepsin in the diagnosis of pyelonephritis: a cross-sectional study
Acute pyelonephritis (n = 35) | Nonpyelonephritis (n = 25) | P-value | |
|---|---|---|---|
Age (years) | 85 [78.0–90.5] | 81 [56.0–88.0] | 0.064 |
Female sex | 25 (71) | 22 (88) | 0.125 |
Diabetes mellitus | 9 (26) | 4 (16) | 0.368 |
Liver cirrhosis | 0 (0) | 1 (4.0) | 0.233 |
Chronic heart failure | 3 (8.6) | 2 (8.0) | 0.937 |
Cerebrovascular disorder | 9 (26) | 2 (8.0) | 0.080 |
Malignant tumor | 3 (8.6) | 3 (12) | 0.663 |
Autoimmune disease | 8 (23) | 5 (20) | 0.791 |
Immunosuppressor | 7 (20) | 3 (12) | 0.412 |
Bacteremia | 8 (23) | 1 (4.0) | 0.044 |
Creatinine (mg/dL) | 0.90 [0.68–1.25] | 0.84 [0.51–1.07] | 0.161 |
eGFR (mL/min/1.73 m2) | 49.0 [38.0–66.5] | 64.0 [42.0–100.0] | 0.122 |
C-reactive protein (mg/L) | 113.4 [50.3–194.1] | 88.9 [29.0–148.9] | 0.393 |
Serum Presepsin (pg/mL) | 361 [302–589] | 386 [251–650] | 0.844 |
Procalcitonin (ng/mL) | 0.38 [0.17–2.06] | 0.19 [0.08–0.94] | 0.097 |